SCHOTT Pharma AG & Co. KGaA (SCHOTT Pharma) develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
Business Segments
The compa…
Analysis
Middle-of-the-road
SCHOTT Pharma AG & Co. KGaA sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is expensive. The owner-earnings multiple stands at 32.8×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 13% a year, against analyst forecasts of 7%. The gap between price and consensus is worth watching: demanding expectations.
Growth is tepid; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202657
41
2026
All-time high
57
Mar 2026
All-time low
41
Jun 2026
Average rank
49
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
48
—
—
—
Price/Earnings
39
—
—
—
Price/Book
54
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
30
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.